Business · 25/04/2023
FDA Requests Public Comment on Proposed Survey on Prescription Drug Advertising
The Food and Drug Administration is seeking public input on a proposed survey about quantitative claims in direct-to-consumer prescription drug advertising, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →